Search

Thyroidectomy can lead to significant challenges such as neck pain, disability, and limited range of motion. Therefore, our objective is to conduct a systematic review and meta‐analysis of clinical trials to investigate the clinical effectiveness of neck stretching exercises in alleviating neck pain and self‐reported disability immediately after thyroidectomy. We systematically searched PubMed, CENTRAL, Scopus, and Web of Science from inception until July 28th, 2023. We assessed the selected trials for the risk of bias using both the RoB‐2 and ROBINS‐I tools. Our specific outcomes were the severity of neck pain and self‐reported disability after thyroidectomy. The results were synthesized using risk ratio (RR) and standardized mean differences (SMD) with 95% confidence intervals (CI) in a random‐effects model using Stata software. Nine clinical trials, comprising five randomized and four non‐randomized trials, were included, with a total of 1026 patients. Neck stretching exercises were significantly associated with improved mean pain scores both after 1 week (n = 625 patients, SMD = −2.43, 95% CI [−4.65, −0.22], p = 0.03, I2 = 98%) and 1 month (n = 545 patients, SMD = −4.11, 95% CI [−8.12, −0.11], p = 0.04, I2 = 99%). Similarly, neck stretching exercises were significantly associated with improved mean self‐reported disability scores both after 1 week (n = 298 patients, SMD = −0.70, 95% CI [−1.36, −0.04], p = 0.04, I2 = 87%) and 1 month (n = 298 patients, SMD = −0.42, 95% CI [−0.65, −0.19], p = 0.0004, I2 = 0%). The pooled analysis showed heterogeneity (chi‐square p < 0.01, I2 > 80%), except for the mean self‐reported neck disability score after 1 month, which showed homogeneity (chi‐square p > 0.01, I2 = 0%). This systematic review and meta‐analysis, involving 1026 patients, revealed the potential benefits of neck stretching exercises in alleviating neck pain and self‐reported disability after thyroidectomy. However, further research is required to address methodological limitations, evaluate long‐term outcomes, investigate potential moderators (i.e., the duration or intensity of the exercise program), and explore patients' analgesic consumption. [ABSTRACT FROM AUTHOR]

The article discusses a study conducted by Kanyo et al. on the outcomes of primary versus salvage laryngectomy with tracheoesophageal prosthesis (TEP) placement. The study found that primary TEP placement during salvage laryngectomy did not increase the risk of complications and showed similar speech and swallow outcomes. The only statistically significant difference between the two cohorts was a higher rate of peristomal dehiscence in the salvage cohort. The authors of the article support the use of primary TEP placement in salvage laryngectomy and suggest that it can expedite speech recovery and improve quality of life for patients. They also mention that national guidelines currently recommend secondary TEP placement in salvage laryngectomy patients, but studies like this one could inform future guidelines. The authors note that their own center has transitioned to primary TEP placement and has seen similar results. They also raise questions about the longer mean time to TEP speech in the study and the increase in peristomal dehiscence, requesting further explanation from the authors. [Extracted from the article]

The last decade has seen the emergence of immune checkpoint inhibitors for the treatment of a wide variety of cancer types. While these medications are generally speaking well tolerated, the full long-term side effect profiles of these medications have not been fully elucidated. We describe a case of chronic rhinosinusitis with nasal polyposis induced treatment with pembrolizumab, the first reported case. We present the case of a 48-year-old man with a background history of stage IV non-small cell lung cancer with bone metastases. He was commenced on pembrolizumab and over the course of the subsequent 5 years he developed significant nasal polyps bilaterally, and was commenced on medical therapy. Sinus CT scan demonstrated bilateral total opacification of all his sinuses and nasal cavity. He subsequently underwent bilateral functional endoscopic sinus surgery. He remains symptom-free and at his last clinical follow-up visit 1 year later. There are limited case reports of nasal polyposis occurring in patients receiving immune checkpoint inhibitors, with only one case requiring surgery. We describe the first case of severe nasal polyps due to pembrolizumab and successfully treated with polypectomy. From our review, there were no cases that required a cessation of therapy. [ABSTRACT FROM AUTHOR]

Purpose: Non-conventional laryngeal malignancies (NSCC) often have limited published data to guide management despite individual histopathological subtypes often exhibiting heterogeneous behaviour, characteristics, and treatment responses compared to laryngeal squamous cell carcinoma (SCC). This study aimed to compare oncological outcomes with SCC, specifically disease-free survival (DFS), disease-specific survival (DSS) and overall survival (OS). Secondary objectives were to compare treatment differences and perform a state of the art review. Methods: This was a multicentre retrospective cohort study at four tertiary head and neck centres. Survival outcomes between NSCC and SCC patients were analysed with Kaplan–Meier curves and compared by log rank testing. Univariate Cox regression analysis was performed to predict survival by histopathological subgroup, T-stage, N-stage and M-stage. Results: There were no significant differences in 3-year DFS (p = 0.499), DSS (p = 0.329), OS (p = 0.360) or Kaplan Meier survival curves (DSS/OS) between SCC and overall NSCC groups. However, univariate Cox regression analysis identified "rare" histopathologies (mostly small cell carcinoma) to be predictive of less favourable OS (p = 0.035) but this result was not observed for other NSCC histopathological subgroups. N-stage (p = 0.027) and M-stage (p = 0.048) also predicted OS for NSCC malignancies. Significant differences in treatment modalities were identified with treatment of NSCC typically involving surgical resection and SCC often managed non-surgically (e.g., primary radiotherapy). Conclusions: Although overall NSCC is managed differently compared to SCC, there do not appear to be differences in survival outcomes between these groups. N-stage and M-stage appear to be more predictive of OS than histopathology than many NSCC subtypes. [ABSTRACT FROM AUTHOR]

Objective: The objective of this study was to explore the pattern of lymph‐node spread of SCCs involving the temporal bone. Methods: We retrospectively reviewed all cutaneous SCCs involving the temporal bone over a 20‐year time‐period. Forty‐one patients were eligible. Results: Mean age was 72.8 years. The diagnosis was cutaneous SCC in all cases. All patients underwent a temporal bone resection, 70.7% had a neck‐dissection and 78.0% a parotidectomy. Level 2 was the most common area of neck metastasis, and occurred in 12.2%. The parotid had disease in 34.1%. 51.2% of patients underwent free‐flap reconstruction. Mean overall survival of the cohort was 4.2 years. Conclusions: Overall, the rate of cervical nodal metastasis was 22.0% and 13.5% in the occult setting. The parotid was involved in 34.1% and 10.0% in the occult setting. Results from the present study support consideration for performing a parotidectomy at the time of temporal bone resection, while a neck dissection can be performed for adequate staging of the nodal basin. Level of Evidence: 3 The objective of the present study was to evaluate the pattern of spread of SCCs involving the temporal bone. The risk of cervical and parotid metastasis was 22.0% and 34.1%, respectively, while the risk of occult disease was 13.5% and 10.0%, respectively. [ABSTRACT FROM AUTHOR]